201 related articles for article (PubMed ID: 18206217)
1. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
3. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
4. Effects of shear stress on protein C activation, EPCR expression and TM expression in endothelial cells.
Jun P; Huangqing C; Xiaoheng L; Ruheng L; Xiaohong Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Apr; 26(2):303-9. PubMed ID: 19499791
[TBL] [Abstract][Full Text] [Related]
5. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
6. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
7. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
8. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
Grey ST; Hancock WW
J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
[TBL] [Abstract][Full Text] [Related]
9. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.
Nan B; Lin P; Lumsden AB; Yao Q; Chen C
Thromb Res; 2005; 115(5):417-26. PubMed ID: 15733976
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
11. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
12. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
13. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
[TBL] [Abstract][Full Text] [Related]
14. Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor.
Bretschneider E; Uzonyi B; Weber AA; Fischer JW; Pape R; Lötzer K; Schrör K
Circ Res; 2007 Feb; 100(2):255-62. PubMed ID: 17170365
[TBL] [Abstract][Full Text] [Related]
15. Decreased protein C activation in patients with fulminant hepatic failure.
Yamaguchi M; Gabazza EC; Taguchi O; Yano Y; Ikoma J; Kaito M; Kojima Y; Imoto I; Satomi A; D'Alessandro-Gabazza CN; Hayashi T; Moriwaki H; Suzuki K; Adachi Y
Scand J Gastroenterol; 2006 Mar; 41(3):331-7. PubMed ID: 16497622
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
Shen L; Villoutreix BO; Dahlbäck B
Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between inflammation and thrombosis.
Esmon CT
Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484
[TBL] [Abstract][Full Text] [Related]
18. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
19. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
